These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7367866)

  • 1. Hydralazine-pyrimidine interactions may explain hydralazine-induced lupus erythematosus.
    Dubroff LM; Reid RJ
    Science; 1980 Apr; 208(4442):404-6. PubMed ID: 7367866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of hydralazine-induced lupus erythematosus with circulating antibodies to native DNA.
    Ohe A; Koda S; Negoro N; Okamura M; Amatsu K; Kohno M; Kanayama Y; Inoue T; Takeda T
    Osaka City Med J; 1982; 28(2):149-51. PubMed ID: 7187014
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular models for hydralazine-related systemic lupus erythematosus.
    Dubroff LM; Reid R; Papalian M
    Arthritis Rheum; 1981 Aug; 24(8):1082-5. PubMed ID: 6974556
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydralazine-induced lupus: yet another autoantibody!
    Pirmohamed M
    Hum Exp Toxicol; 1996 Apr; 15(4):361-2. PubMed ID: 8845227
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the pathogenesis of hydralazine-induced lupus erythematosus-like syndrome (author's transl)].
    Yamauchi Y
    Ryumachi; 1979 Apr; 19(2):88-104. PubMed ID: 312536
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune responses to hydralazine and nuclear antigens in hydralazine-induced lupus erythematosus.
    Hahn BH; Sharp GC; Irvin WS; Kantor OS; Gardner CA; Bagby MK; Perry HM; Osterland CK
    Ann Intern Med; 1972 Mar; 76(3):365-74. PubMed ID: 4536922
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibodies to dsDNA in drug induced lupus erythematosus.
    Cohen MG
    J Rheumatol; 1994 Mar; 21(3):578-9. PubMed ID: 8006909
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiac tamponade in hydrallazine-induced systemic lupus erythematosus.
    Aylward PE; Tonkin AM; Bune A
    Aust N Z J Med; 1982 Oct; 12(5):546-7. PubMed ID: 6960881
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe hydralazine-induced lupus presenting as systemic lupus erythematosus.
    Rubin RL; Haluptzok RF; Davila LM
    Lupus; 2020 Apr; 29(5):509-513. PubMed ID: 32041503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydralazine-induced lupus erythematosus-like syndrome.
    Irias JJ
    Am J Dis Child; 1975 Jul; 129(7):862-4. PubMed ID: 50009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Aetiology of systemic lupus erythematosus.
    McEwen J
    Lancet; 1974 Dec; 2(7896):1570. PubMed ID: 4141003
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility.
    Batchelor JR; Welsh KI; Tinoco RM; Dollery CT; Hughes GR; Bernstein R; Ryan P; Naish PF; Aber GM; Bing RF; Russell GI
    Lancet; 1980 May; 1(8178):1107-9. PubMed ID: 6103441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orogenital ulcers, SLE and hydralazine.
    Neville E; Graham PY; Brewis RA
    Postgrad Med J; 1981 Jun; 57(668):378-9. PubMed ID: 7301684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocytotoxic antibodies in hydralazine-induced lupus erythematosus.
    Ryan PF; Hughes GR; Bernstein R; Mansilla R; Dollery CT
    Lancet; 1979 Dec; 2(8154):1248-9. PubMed ID: 92663
    [No Abstract]   [Full Text] [Related]  

  • 15. Sweet syndrome associated with hydralazine-induced lupus erythematosus.
    Cartee TV; Chen SC
    Cutis; 2012 Mar; 89(3):121-4. PubMed ID: 22530328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of immune response to hydralazine and development of antideoxyribonucleoprotein in patients receiving hydralazine.
    Carpenter JR; McDuffie FC; Sheps SG; Spiekerman RE; Brumfield H; King R
    Am J Med; 1980 Sep; 69(3):395-400. PubMed ID: 6968159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus.
    Nässberger L; Sjöholm AG; Jonsson H; Sturfelt G; Akesson A
    Clin Exp Immunol; 1990 Sep; 81(3):380-3. PubMed ID: 2168822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydralazine and lupus nephritis.
    Ihle BU; Whitworth JA; Dowling JP; Kincaid-Smith P
    Clin Nephrol; 1984 Nov; 22(5):230-8. PubMed ID: 6240359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydralazine hoarseness. A new appearance of drug-induced systemic lupus erythematosus.
    Weiser GA; Forouhar FA; White WB
    Arch Intern Med; 1984 Nov; 144(11):2271-2. PubMed ID: 6497533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced lupus erythematosus.
    Blomgren SE
    Semin Hematol; 1973 Oct; 10(4):345-9. PubMed ID: 4803375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.